MDX-060: Phase I/II ongoing

In an open-label, dose-escalation, U.S. Phase I/II trial in 56

Read the full 100 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE